Approval · Notice of Compliance 6430 · 2005
PROGRAF: Notice of Compliance 6430
Issued April 12, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6430
- Date
- April 12, 2005
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Immunosuppressant
Products in this notice
Medicinal ingredients
- TACROLIMUS 5 MG per ML
- TACROLIMUS 0.5 MG per CAP
- TACROLIMUS 1 MG per CAP
- TACROLIMUS 5 MG per CAP